Trial intelligence / Profile preview

Short-term vs standard cefazolin prophylaxis in renal transplantation

2007-004284-21Phase 4Completed

Sponsor
Policlinico Gemelli
Start
Jan 2008
Modality
Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of cefazolin in Infection (2 arms), sponsored by Policlinico Gemelli. Primary endpoints: Incidence of infections, Toxicity and 3 more. Started Jan 2008; status: completed.

02

Drugs

cefazolin
03

Conditions

Infection

Beyond the preview

Go deeper on 2007-004284-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-004284-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call